Insurance; require coverage for diagnosis and treatment of pediatric autoimmune neuropsychiatric disorders; provisions
Insurance; require coverage for healthcare services for pediatric autoimmune neuropsychiatric disorders; provisions
Insurance; pediatric autoimmune neuropsychiatric disorders; require coverage for healthcare services
To Mandate Coverage For Use Of Intravenous Immunoglobulin To Treat Certain Pediatric Disorders Caused By Infections; And To Declare An Emergency.
Mandating insurance coverage for pediatric acute-onset neuropsychiatric syndrome (PANS) and pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections (PANDAS).
Removes the sunset provision of all statutory law requiring coverage for the treatment of pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections and pediatric acute onset neuropsychiatric syndrome.
Removes the sunset provision of all statutory law requiring coverage for the treatment of pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections and pediatric acute onset neuropsychiatric syndrome.
Removes the sunset provision of all statutory law requiring coverage for the treatment of pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections and pediatric acute onset neuropsychiatric syndrome.
Insurance: insurers; coverage for certain pediatric autoimmune neuropsychiatric disorders; require. Amends 1956 of 218 (MCL 500.100 - 500.8302) by adding sec. 3406pp.
Requiring coverage of treatment for certain pediatric autoimmune neuropsychiatric disorders in certain circumstances